Genome Report | Genome Report
Microbiol. Biotechnol. Lett. 2024; 52(4): 496-499
https://doi.org/10.48022/mbl.2404.04008
Yong-Seok Kim† and Chang-Jun Cha*
Department of Systems Biotechnology and Center for Antibiotic Resistome, Chung-Ang University, Anseong 17546, Republic of Korea
†Present address: DNA Link, Inc., Seoul 07793, Republic of Korea
Correspondence to :
Chang-Jun Cha, cjcha@cau.ac.kr
Multidrug-resistant Pseudomonas asiatica CJ23 was isolated from the soil in a lettuce cultivation field, South Korea. The genome of strain CJ23 comprising 5,715,627 bp was assembled to a single contig with a G + C content of 62.7%. The complete genome sequence contained 5,092 protein-coding genes, 22 rRNA genes, and 74 tRNA genes. The genome of strain CJ23 possessed resistance-nodulation-division (RND)-type multidrug efflux pump, ampC β-lactamase and two metal resistance genes.
Keywords: Pseudomonas asiatica, complete genome, multidrug-resistant bacteria
The genus
Members of the genus are generally aerobic, Gram-staining-negative, rod-shaped, and motile with one or more polar flagella. The genome sequences of
In this study, a multidrug-resistant
The genomic DNA was extracted using FastDNA™ Spin Kit for Soil (MP Biomedicals) following the manufacturer’s protocols. Whole genome sequencing of strain CJ23 was carried out at DNA Link, Inc. (Republic of Korea) using the Oxford Nanopore MinION flow cell (R9.4.1 FLO-MIN106, Oxford Nanopore) and the Illumina NovaSeq 6000 sequencing platforms. The genomic DNA of strain CJ23 for the nanopore sequencing was prepared using the Ligation Sequencing Kit SQK-LSK109 (Oxford Nanopore, UK) following the manufacturer’s protocol. The genomic DNA library for Illumina sequencing was prepared according to TruSeq DNA PCR-Free kit manufacturer’s protocol. Genome assembly was performed using Trycycler v0.5.4 [4] following the recommended workflow [5], and error correlation and polishing were performed using medaka v1.11.3 (https://github.com/nanoporetech/medaka) based on long-read sequencing data. To obtain a more refined genome sequence, additional error correlation and polishing steps were performed using polypolish v0.5.0 [6] and polca v3.4.2 [7] based on short-read sequencing data. Genome completeness was evaluated using BUSCO v5.6.1 [8] and CheckM v1.2.2 [9]. Average nucleotide identity (ANI) value was calculated by the OrthoANI algorithm [10]. The assembled genome was visualized using Genovi v0.2.16 [11] and genome annotation was performed using bakta v 1.9.1 [12]. Antibiotic resistance genes and metal resistance genes were predicted using NCBI Antimicrobial Resistance Gene Finder v3.11.2 [13]. The antibiotic susceptibility of strain CJ23 was tested by the disk diffusion assay using antibiotic impregnated disks (Lioflchem, Italy) including amoxicillin (10 μg), cephalexin (30 μg), chloramphenicol (30 μg), ciprofloxacin (5 μg), gentamicin (10 μg), meropenem (10 μg), streptomycin (10 μg), sulfamethoxazole (50 μg), tetracycline (30 μg), and trimethoprim (5 μg). Susceptibility results were recorded as susceptible (S), intermediate (I) or resistant (R) based on breakpoints according to the CLSI M100 clinical breakpoint table.
The sequencing depth was 281.14 × coverage and the completeness of genome assembly was determined to be 99.8% and 99.9% based on BUSCO and CheckM, respectively. The genome size of strain CJ23 was 5,715,627 bp comprising a single contig with a G + C content of 62.7%(Fig. 1). The genome sequence contained 5,092 protein-coding genes (CDSs), 22 rRNA genes (seven rRNA operons and one 5S ribosomal RNA gene) and 74 tRNA genes (Table 1). The 16S rRNA sequence similarity between strain CJ23 and
Table 1 . Genome feature of
Features | Value |
---|---|
No. of contigs | 1 |
Genome size (bp) | 5,715,627 |
G + C ratio (%) | 62.7 |
N50 | 5,715,627 |
No. of CDSs | 5,092 |
No. of rRNA (5S, 16S, 23S) genes | 22 (8, 7, 7) |
No. of tRNA genes | 74 |
No. of ncRNA genes | 67 |
GenBank accession No. | CP150846 |
Antibiotic resistance profile (R)* | Amoxicillin, Cephalexin, Gentamicin, Meropenem, Streptomycin, Trimethoprim |
Antibiotic resistance profile (I)* | Chloramphenicol, Ciprofloxacin |
*Susceptibility results were recorded as resistant (R) or intermediate (I) based on breakpoints according to the CLSI M100 clinical breakpoint table.
다제내성
This research was supported by the research program for Agricultural Science & Technology Development under the National Institute of Agricultural Science (NAS)-Rural Development Administration (RDA), South Korea, under grant numbers PJ015130, and the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIT) (NRF-2023R1A2C1003654).
The authors have no financial conflicts of interest to declare.
Da-Ryung Jung, Tino Bashizi, and Jae-Ho Shin
Microbiol. Biotechnol. Lett. 2024; 52(4): 493-495 https://doi.org/10.48022/mbl.2401.10013Da-Ryung Jung, GyuDae Lee, Tino Bashizi, and Jae-Ho Shin
Microbiol. Biotechnol. Lett. 2023; 51(4): 548-550 https://doi.org/10.48022/mbl.2310.10017Haeseong Lee, Jae-Young Oh, Kui Jae Lee, and Jong-Chan Chae
Microbiol. Biotechnol. Lett. 2023; 51(4): 545-547 https://doi.org/10.48022/mbl.2311.11010